Trial Profile
Study of desensitization with plasmapheresis and bortezomib in heart transplantation patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 07 Aug 2015 New trial record